Search Thermo Fisher Scientific
Search Thermo Fisher Scientific
FIGURE: 1 / 1
The autosomal dominant cerebellar ataxias (ADCAs) are a clinically and genetically heterogeneous group of disorders characterized by ataxia, dysarthria, dysmetria, and intention tremor. All ADCAs involve some degree of cerebellar dysfunction and a varying degree of signs from other components of the nervous system. A commonly accepted clinical classification (Harding, 1993) divides ADCAs into 3 different groups based on the presence or absence of associated symptoms such as brainstem signs or retinopathy. The presence of pyramidal and extrapyramidal symptoms and ophthalmoplegia makes the diagnosis of ADCA I, the presence of retinopathy points to ADCA II, and the absence of associated signs to ADCA III. Genetic linkage and molecular analyses revealed that ADCAs are genetically heterogeneous even within the various subtypes.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Protein Aliases: ataxin 10 homolog; Ataxin-10; Brain protein E46; Brain protein E46 homolog; Neuronal beta-catenin-like protein; spinocerebellar ataxia 10; spinocerebellar ataxia 10 homolog; Spinocerebellar ataxia type 10 protein; Spinocerebellar ataxia type 10 protein homolog; testis expressed gene 169
Gene Aliases: AI325283; ATXN10; C77170; E46; E46L; HUMEEP; SCA10; TEG-169; Tex169
UniProt ID: (Human) Q9UBB4, (Rat) Q9ER24, (Mouse) P28658
Entrez Gene ID: (Human) 25814, (Rat) 170821, (Mouse) 54138
If an Invitrogen™ antibody doesn't perform as described on our website or datasheet,we'll replace the product at no cost to you, or provide you with a credit for a future purchase.*
Learn moreGet expert recommendations for common problems or connect directly with an on staff expert for technical assistance related to applications, equipment and general product use.
Contact tech support